Global Precision Immuno-Oncology Market Size, Share, Growth Analysis, By End use, By Cancer type, By Treatment type, By Biomarker

Description

Market Insights

Global Precision Immuno-Oncology Market size was valued at USD 49.4 billion in 2021 and is poised to grow from USD 54.74 billion in 2022 to USD 124.33 billion by 2030, growing at a CAGR of 10.8% in the forecast period (2023-2030).

Global Precision Immuno-Oncology is an advanced and promising field in cancer treatment, utilizing precise and personalized approaches to target and eradicate cancer cells. By combining immunotherapy with precision medicine, this innovative approach aims to enhance the effectiveness of cancer treatment while minimizing side effects. Cutting-edge technologies, such as next-generation sequencing and biomarker analysis, play a crucial role in identifying specific tumor characteristics and guiding treatment decisions. With ongoing research and clinical trials, Precision Immuno-Oncology holds great potential in revolutionizing cancer care and improving patient outcomes worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of Precision Immuno-Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Precision Immuno-Oncology Market Segmental Analysis

Precision Immuno-Oncology Market is segmented on the basis of Treatment type, cancer type, end-user, biomarker, and region. By end use, the Precision Immuno-Oncology Market is segmented into hospitals, clinics, research institutes, and others. By cancer type, the Precision Immuno-Oncology Market is segmented into Lung cancer, Breast cancer, Prostate cancer, Melanoma, and others. By treatment type, the Precision Immuno-Oncology Market is segmented into immune checkpoint inhibitors, car T cell therapy, cancer vaccines, and others. By biomarker, the Precision Immuno-Oncology Market is segmented into PD-L1, BRCA, KRAS, EGFR, and others. By region, the Precision Immuno-Oncology Market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver

The increasing prevalence of cancer is expected to drive the demand for Precision Immuno-Oncology. As cancer cases continue to rise, there is a growing need for more effective and targeted treatment options. Precision Immuno-Oncology offers the potential to tailor cancer therapies to individual patients based on their specific tumor characteristics and immune responses. By harnessing the power of the immune system to fight cancer, this emerging field holds promise in improving treatment outcomes and addressing the challenges posed by various types of cancer.

Restraints

The growth of the Global Precision Immuno-Oncology market is impeded by the significant cost associated with its implementation. The advanced technologies and personalized nature of precision immuno-oncology therapies can be financially challenging for both healthcare providers and patients. The high cost of treatments may limit accessibility and adoption, hindering the market's potential growth. Addressing these cost-related challenges through research, development, and innovative pricing strategies will be crucial to overcome this restraint and unlock the full potential of precision immuno-oncology in cancer treatment.

Market Trends

In precision immuno-oncology treatments is the increasing utilization of combination therapies alongside traditional cancer treatments like chemotherapy and radiation therapy. This approach has gained popularity due to its potential to enhance treatment effectiveness and combat treatment resistance. For instance, the combination of immunotherapy and chemotherapy has shown promising outcomes in treating certain cancer types like lung cancer and melanoma. While chemotherapy reduces tumor size, immunotherapy helps the patient's immune system recognize and attack cancer cells more effectively.

Product Code: SQMIG35H2063

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Precision Immuno-Oncology Market by End use

Market Overview
Hospital
Clinics
research institutes and others

Global Precision Immuno-Oncology Market by Cancer type

Market Overview
Lung cancer
breast cancer
prostate cancer
melanoma and others

Global Precision Immuno-Oncology Market by Treatment type

Market Overview
checkpoint inhibitors
car T cell therapy
cancer vaccines
and others

Global Precision Immuno-Oncology Market by Biomarker

Market Overview
PD-L1
BRCA
KRAS
EGFR
and others.

Global Precision Immuno-Oncology Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Adaptimmune Therapeutics plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agenus Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol Myers Squibb Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celgene Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gilead Sciences, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Iovance Biotherapeutics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Juno Therapeutics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kite Pharma, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neon Therapeutics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seattle Genetics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

Global Precision Immuno-Oncology Market Size, Share, Growth Analysis, By End use, By Cancer type, By Treatment type, By Biomarker - Industry Forecast 2023-2030